Ownership

George A. Samuel III - General Counsel at Lineage Cell Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: General Counsel
Stock Symbol: LCTX on NYSE
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

George A. Samuel III - trading volume in the past year for Lineage Cell Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+15K	100%	$0.60	+$9K
Sells
Net	+15K	100%		+$9K

Holdings reported by George A. Samuel III for Lineage Cell Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Shares	22.2K	$13.3K	$0.60	Nov 26, 2024	Direct
Common Shares, no par value	7.18K	$7.76K	$1.08	Feb 11, 2024	Direct
Employee Stock Option (Right to Buy)	650K			Mar 7, 2024	Direct	Common Shares
Restricted Stock Units	12.2K			Feb 11, 2024	Direct	Common Shares

Transactions reported by George A. Samuel III for Lineage Cell Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.